Depression and the Usefulness of a Disease Management Program in Heart Failure Insights From the COACH (Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure) Study

被引:40
作者
Jaarsma, Tiny [1 ]
Lesman-Leegte, Ivonne [1 ]
Hillege, Hans L. [1 ,3 ]
Veeger, Nic J. [3 ]
Sanderman, Robbert [2 ]
van Veldhuisen, Dirk J. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol RS, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands
关键词
depressive symptoms; disease management; heart failure; RANDOMIZED-TRIAL; CARE; INTERVENTION; NONCOMPLIANCE; CLINICS; RISK;
D O I
10.1016/j.jacc.2009.11.082
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Our aim was to study the possible role of depressive symptoms in the effectiveness of a disease management program (DMP) in heart failure (HF) patients. Background Disease management programs are recommended in current HF guidelines, but certain patient groups, such as those with depression, might be less responsive to such programs. Methods From the data of a large multicenter study, in which we examined the effect of a DMP in HF patients, we investigated a potential interaction between depressive symptoms at baseline and the effect of such a program. Results Of the 958 HF patients (37% female; age 71 +/- 11 years; New York Heart Association functional class II to IV), 377 (39%) reported depressive symptoms at baseline. During 18 months of follow-up, the primary end point (composite of all-cause mortality and HF readmission) occurred in 39% of the nondepressed patients and 42% of depressed patients. In the overall sample, there was no significant effect of DMP on the composite primary end point. The effect of the DMP was significantly different in nondepressed than in depressed HF patients. A significant effect modification by depressive symptoms was observed in evaluating the effect of the DMP on all-cause mortality and HF readmission (p = 0.03). In patients without depressive symptoms, DMP resulted in a trend for lower incidence of the primary end point (hazard ratio: 0.8, 95% confidence interval: 0.61 to 1.04), whereas the reverse was observed in patients with depressive symptoms (hazard ratio: 1.3, 95% confidence interval: 0.95 to 1.98). Conclusions Depressive symptoms in patients with HF have a major effect on the usefulness of DMP. Identification of depressive symptoms before enrollment in a DMP might lead to more accurate use of a DMP, because depressive patients might not benefit from a general program. (Netherlands Heart Foundation Coordinating study evaluating Outcomes of Advising and Counselling in Heart Failure; ISRCTN98675639) (J Am Coll Cardiol 2010; 55: 1837-43) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:1837 / 1843
页数:7
相关论文
共 28 条
[1]   Executive summary:: HFSA 2006 comprehensive heart failure practice guideline [J].
Adams, KF ;
Lindenfeld, J ;
Arnold, JMO ;
Baker, DW ;
Barnard, DH ;
Baughman, KL ;
Boehmer, JP ;
Deedwania, P ;
Dunbar, SB ;
Elkayam, U ;
Gheorghiade, M ;
Howlett, JG ;
Konstam, MA ;
Kronenberg, MW ;
Massie, BM ;
Mehra, MR ;
Miller, AB ;
Moser, DK ;
Patterson, JH ;
Rodeheffer, RJ ;
Sackner-Bernstein, J ;
Silver, MA ;
Starling, RC ;
Stevenson, LW ;
Wagoner, LE ;
Francis, GS ;
Bristow, MR ;
Cohn, JN ;
Colucci, WS ;
Greenberg, BH ;
Force, T ;
Krumholz, HM ;
Liu, PP ;
Mann, DL ;
Piña, IL ;
Pressler, SJ ;
Sabbah, HN ;
Yancy, CW .
JOURNAL OF CARDIAC FAILURE, 2006, 12 (01) :10-38
[2]   Developing an intervention for depressed, chronically medically ill elders: a model from COPD [J].
Alexopoulos, George S. ;
Raue, Patrick J. ;
Sirey, Jo Anne ;
Arean, Patricia A. .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (05) :447-453
[3]   The future of management programmes for heart failure [J].
Clark, Alexander M. ;
Thompson, David R. .
LANCET, 2008, 372 (9641) :784-786
[4]   Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death - The trans-European network-home-care management system (TEN-HMS) study [J].
Cleland, JGF ;
Louis, AA ;
Rigby, AS ;
Janssens, U ;
Balk, AHMM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) :1654-1664
[5]   Nonresponse to treatment for depression following myocardial infarction: Association with subsequent cardiac events [J].
de Jonge, Peter ;
Honig, Adriaan ;
van Melle, Joost P. ;
Schene, Aart H. ;
Kuyper, Astrid M. G. ;
Tulner, Dorien ;
Schins, Annique ;
Ormel, Johan .
AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (09) :1371-1378
[6]   ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) [J].
Dickstein, Kenneth ;
Cohen-Solal, Alain ;
Filippatos, Gerasimos ;
McMurray, John J. V. ;
Ponikowski, Piotr ;
Poole-Wilson, Philip Alexander ;
Stromberg, Anna ;
van Veldhuisen, Dirk J. ;
Atar, Dan ;
Hoes, Amo W. ;
Keren, Andre ;
Mebazaa, Alexandre ;
Nieminen, Markku ;
Priori, Silvia Gluliana ;
Swedberg, Karl .
EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (10) :933-989
[7]   Depression is a risk factor for noncompliance with medical treatment -: Meta-analysis of the effects of anxiety and depression on patient adherence [J].
DiMatteo, MR ;
Lepper, HS ;
Croghan, TW .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (14) :2101-2107
[8]   Psychological distress and cardiovascular disease: results from the 2002 National Health Interview Survey [J].
Ferketich, AK ;
Binkley, PF .
EUROPEAN HEART JOURNAL, 2005, 26 (18) :1923-1929
[9]   Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction [J].
FrasureSmith, N ;
Lesperance, F ;
Prince, RH ;
Verrier, P ;
Garber, RA ;
Juneau, M ;
Wolfson, C ;
Bourassa, MG .
LANCET, 1997, 350 (9076) :473-479
[10]   Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial [J].
Granger, BB ;
Swedberg, K ;
Ekman, I ;
Granger, CB ;
Olofsson, B ;
McMurray, JJV ;
Yusuf, S ;
Michelson, EL ;
Pfeffer, MA .
LANCET, 2005, 366 (9502) :2005-2011